glp 1 drugs for alcohol GLP-1 Weight Loss and Alcohol: Why Ozempic Reduces Both Researchers seek to explain why

& Salakhutdinov, R

The incretin effect was estimated to account for approximately 50% - 70% of the postprandial insulin responses in healthy individuals and may be substantially reduced to 20% 30% in individuals with type 2 diabetes mellitus (T2DM) (6, 7), a complex disorder arising from inadequate compensation of insulin secretion by pancreas to counter peripheral insulin resistance

Patients should be counselled that regaining weight after stopping GLP-1 RAs can reverse improvements, potentially requiring medications to be resumed

Another patient group who might benefit from treatment with GLP-1R agonists is gastric by-pass patients who increase their alcohol intake after surgery

What happens if GLP-1/GIP agonists become widely covered by commercial insurers or Medicare

Landmark trials showed robust weight loss with both semaglutide and tirzepatide